Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Sekiguchi

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 26, 2000
Reduced voltage sensitivity of activation of P/Q-type Ca2+ channels is associated with the ataxic mouse mutation rolling Nagoya (tg(rol))Y Mori, M Wakamori, S Oda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 21, 2005
Long-term follow-up results of no initial therapy for ocular adnexal MALT lymphomaK Tanimoto, A Kaneko, S Suzuki, et al.
Rheumatology (Oxford, England)|April 5, 2008
Messenger ribonucleic acid expression profile in peripheral blood cells from RA patients following treatment with an anti-TNF-alpha monoclonal antibody, infliximabN Sekiguchi, S Kawauchi, T Furuya, et al.
Current Medicinal Chemistry|July 23, 2003
A possible target of antioxidative therapy for diabetic vascular complications-vascular NAD(P)H oxidaseT Inoguchi, H Tsubouchi, T Etoh, et al.
Heart and Vessels|January 1, 1997
Anti-atherogenicity in women does not prevent restenosis after balloon angioplastyT Watanabe, S Isoyama, A Nakamura, et al.
Blood Cancer Journal|February 28, 2015
t(14;16)-positive multiple myeloma shows negativity for CD56 expression and unfavorable outcome even in the era of novel drugsT Narita, A Inagaki, T Kobayashi, et al.
The Journal of Steroid Biochemistry and Molecular Biology|March 23, 2010
A novel nonsecosteroidal VDR agonist (CH5036249) exhibits efficacy in a spontaneous benign prostatic hyperplasia beagle modelK Taniguchi, K Katagiri, H Kashiwagi, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 26, 2000
Reduced voltage sensitivity of activation of P/Q-type Ca2+ channels is associated with the ataxic mouse mutation rolling Nagoya (tg(rol))Y Mori, M Wakamori, S Oda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 21, 2005
Long-term follow-up results of no initial therapy for ocular adnexal MALT lymphomaK Tanimoto, A Kaneko, S Suzuki, et al.
Rheumatology (Oxford, England)|April 5, 2008
Messenger ribonucleic acid expression profile in peripheral blood cells from RA patients following treatment with an anti-TNF-alpha monoclonal antibody, infliximabN Sekiguchi, S Kawauchi, T Furuya, et al.
Current Medicinal Chemistry|July 23, 2003
A possible target of antioxidative therapy for diabetic vascular complications-vascular NAD(P)H oxidaseT Inoguchi, H Tsubouchi, T Etoh, et al.
Heart and Vessels|January 1, 1997
Anti-atherogenicity in women does not prevent restenosis after balloon angioplastyT Watanabe, S Isoyama, A Nakamura, et al.
Blood Cancer Journal|February 28, 2015
t(14;16)-positive multiple myeloma shows negativity for CD56 expression and unfavorable outcome even in the era of novel drugsT Narita, A Inagaki, T Kobayashi, et al.
The Journal of Steroid Biochemistry and Molecular Biology|March 23, 2010
A novel nonsecosteroidal VDR agonist (CH5036249) exhibits efficacy in a spontaneous benign prostatic hyperplasia beagle modelK Taniguchi, K Katagiri, H Kashiwagi, et al.
Pageof 6